United Therapeutics Corporation Inventory, Finished Goods, Net of Reserves
United Therapeutics Corporation (UTHR) had Inventory, Finished Goods, Net of Reserves of $124.10 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $124.10M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $108.60M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $117.20M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $110.50M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $124.10M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $108.60M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $117.20M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $110.50M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $103.00M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $97.00M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $95.00M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $90.20M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $80.10M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $63.80M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $55.70M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $47.90M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $48.70M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $52.30M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $50.70M 10-K · filed 2024-02-21 | |
| 2022-09-30 | $39.90M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $40.30M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $41.20M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $44.30M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $49.50M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $44.80M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $45.00M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $38.60M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $38.00M 10-Q · filed 2020-10-28 | |
| 2020-06-30 | $42.90M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $43.80M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $43.20M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $45.00M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $48.10M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $47.60M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $48.70M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $49.40M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $49.70M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $52.10M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $55.90M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $62.20M 10-Q · filed 2017-10-25 | |
| 2017-06-30 | $61.60M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $57.50M 10-Q · filed 2017-04-26 | |
| 2016-12-31 | $49.70M 10-K · filed 2018-02-21 | |
| 2016-09-30 | $41.50M 10-Q · filed 2016-10-27 | |
| 2016-06-30 | $37.30M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $38.10M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $35.70M 10-K · filed 2017-02-22 | $35.75M 10-K · filed 2016-02-25 |
| 2015-09-30 | $33.44M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $32.97M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $30.14M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $29.62M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $27.01M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $22.36M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $19.81M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $17.58M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $17.17M 10-Q · filed 2013-10-29 | |
| 2013-06-30 | $14.46M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $12.92M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $11.94M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $23.30M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $22.41M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $22.74M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $22.59M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $22.06M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $19.48M 10-Q · filed 2011-07-28 | |
| 2010-12-31 | $13.10M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |